TG Therapeutics Claimed Company
TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. read more
HR or Marketing? Claim Your Free Employer Account
TG Therapeutics Interviews Employee Reviews
All
Positive
Constructive
What did you like most about the interview process?
At the time I interviewed, it was a group interview, and I enjoyed that
What would you improve about your company's interview process?
The interview process was 'made to look important' It was average at best. If you really wanted to get the job, you basically have to fit in with the people that are the strong suiters of that circle.
Better training those who are taking a leadership role.
×